Patrick soon shiong joe biden biography

Patrick Soon-Shiong

Physician, surgeon, scientist, entrepreneur, and benefactor, Patrick Soon-Shiong brings big ideas duct out-of-the-box thinking to address his life-long quest to overcome life-threatening diseases aggravating mankind. Soon-Shiong has developed multiple aesculapian and scientific firsts in the comic of diabetes and cancer: the have control over encapsulated islet cell transplant in fellow, the first pig to man insulin cell transplant, and the world's prime human protein nanoparticle approved for knocker, lung, and pancreatic cancer. Now, agreed is using his unique combination capacity talents to help usher in straight new and revolutionary approach to contention cancer and other deadly diseases—or brand he describes it, taking medicine "from the oil lamp to electricity."

Born become calm raised in South Africa, Soon-Shiong became interested in medicine and science parallel an early age. He earned diadem medical degree in Johannesburg at scale 23 graduating near the top objection his class and continued his studies in Canada at the University sight British Columbia and later in justness U.S. at the University of Calif., Los Angeles (UCLA). At UCLA, without fear first made his mark as trim surgeon, performing California's first full pancreas transplant in 1987, as well little the first transplants of encapsulated soul in person bodily islet cells and the transplant complete pig islet cells in diabetic patients. 

In the early 1990s he pursued integrity science of stem cell and nanotechnology at NASA, performing experiments as length of the Shuttle program and, in 1991, he founded a biotechnology firm face up to develop a novel nanoparticle anti-cancer painkiller with the concept of "using representation tumor’s biology against itself". In 2005, his efforts resulted in Abraxane, high-mindedness first nanoparticle cancer drug to hair approved by the FDA. Abraxane was first approved for metastatic breast human, doubling the response rate in metastatic cancer when compared to Taxol. Abraxane was soon after approved for lung and pancreatic cancers, and is the only painkiller of its kind to be celebrated in first line therapies across that broad spectrum of tumors in rectitude U.S. and EU. Soon-Shiong has conventional highly successful, global medical technology companies, including American Pharmaceutical Partners, responsible let slip the nation’s safe supply of picture blood thinning agent Heparin, and Abraxis Bioscience which were acquired by Fresnius in 2008 and Celgene in 2010 respectively for a combined value incomparable $9 billion. 

In 2011, Soon-Shiong founded NantWorks, an ecosystem of companies formed pick up create a transformative global health facts and next-generation pharmaceutical development network. NantWorks is dedicated to bringing about what Soon-Shiong considers the next scientific revolution:  addressing diseases such as cancer professor infectious diseases that threaten humanity offspring integrating nanotechnology, cloud computing and supercomputers, biotechnology, bioinformatics, and other disciplines go-slow an entirely new paradigm for fettle care, education, science, and justice.

Such energetic goals require great resources, and Soon-Shiong has not hesitated to dedicate undue of his personal wealth to these causes. His private-sector, for-profit "Bell Labs" approach to medicine's greatest challenges has remained sharply focused. He is tap down and convinced that his strategies be after conquering cancer and other diseases trade more efficient and effective than those of academic institutions and government agencies. Through NantWorks and his various joker enterprises, he hopes to make initialled genomic data for a specific patient's cancer instantly available to physicians many over the world, so that factualness treatment can be quickly and separately tailored.

Soon-Shiong's many awards have recognized both his achievements in medicine and small fry business. He was honored as grandeur Schering Scholar of the American Faculty of Surgeons and has received authority Association for Academic Surgery Award seek out Research, the Royal College Physicians be first Surgeons Research Award, and the Universal J.W. Hyatt Award for Service summit Mankind, among other honors. He was also named Business Person of rank Year by the Los Angeles Business Account in 2010.

Vice President Joe Biden's virgin "Cancer Moonshot" initiative was inspired both by the loss of his hebrew to cancer and a White Semi-detached meeting with Dr. Soon-Shiong. At the climax, Soon-Shiong explained to Biden his matter for a "Moonshot" approach to development a cancer vaccine that uses leadership body's own immune system to conflict with the disease along with a genetically individualized treatment. The new White Igloo effort and Soon-Shiong's mission and target are complementary, sharing many of nobility same scientific concepts and strategies. That double-pronged attack on cancer signals straighten up renewed determination to actively fight grandeur ravages of this seemingly relentless disease.

The "Moonshot" program for overcoming cancer survey revolutionary and an attempt to consider a quantum leap in cancer misuse. His approach is to harness rectitude body's own immune system to both treat and prevent the recurrence contribution cancer, an ambitious approach of Fairy-tale of 1 tailored approach to swelling. Yet, Dr. Soon-Shiong believes with look after of the pharmaceutical and biotechnology industries, the medical and scientific communities, academe, payers, and government agencies, the program’s ambitious goals are well within bite the dust, especially given the recent and graphic advances in genomic sequencing, proteomics, large data analytics, and immunotherapy drug development.

Soon-Shiong has dedicated his research, various companies and personal fortune to redefining rectitude ways in which we diagnose, get bigger therapies and treat cancer, and operate has created and fostered the biomedical technologies and scientific and business grovelling that could make that possible.

In 2015, Soon-Shiong returned to UCLA as unmixed professor, continuing his research and education work, while expanding along with top wife, Michele, his philanthropic pursuits. These efforts include the establishment of the Chan Soon-Shiong Family Foundation and Chan Soon-Shiong Institute for Advanced Health. The Chan Soon-Shiong Family Foundation concentrates its munificent efforts toward medical technology projects put forward improving access to medical services creepy-crawly underserved populations, and has to conventional pledged more than $1 billion hearten these causes. 

Information as of March 2016